초록
<P>Astaxanthin is a carotenoid of high commercial value because of its excellent antioxidative, anti-inflammatory, and anticancer properties. Here, we developed a novel strategy for improving the production of astaxanthin via morphology and oxidative stress engineering. First, we identified the morphology-/membrane- and oxidative stress-related genes, which should be knocked down, using the CRISPRi system. Deleting the morphology-/membrane-related genes (<I>lpp</I> and <I>bamB</I>) and the oxidative stress-related genes (<I>uspE</I> and <I>yggE</I>) generated longer and larger cells with higher reactive oxygen species (ROS) levels, thus enhancing the production of astaxanthin and decreasing cell growth. To not only improve cell growth but also obtain longer and larger cells with higher ROS levels, a complementary expression system using a temperature-sensitive plasmid was established. Complementarily expressing the morphology-/membrane-related genes (<I>lpp</I> and <I>bamB</I>) and the oxidative stress-related genes (<I>uspE</I> and <I>yggE</I>) further improved the production of astaxanthin to 11.92 mg/g dry cell weight in shake flask cultures.</P><BR>[FIG OMISSION]</BR>